NCT01290965View on ClinicalTrials.gov

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Chronic Hepatitis C
Interventions
DRUG

Placebo

Oral tablet given once or three times daily for 15 consecutive days

DRUG

SCY-635

oral capsule

Trial Locations (2)

23249

McGuire Veterans Affairs Medical Center, Richmond

94115

Quest Clinical Research, San Francisco

All Listed Sponsors
lead

Scynexis, Inc.

INDUSTRY

NCT01290965 - Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients | Biotech Hunter | Biotech Hunter